NSECertificate under SEBI (Depositories and Participants) Regulations, 20187 Jul 2026 · 7 Jul 2026, 06:19 pm
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Emcure Pharmaceuticals Limited · EMCURE
✦ AI Summary
Emcure Pharmaceuticals Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018. The company has received a Confirmation Certificate from MUFG Intime India Private Limited, the Registrar and Share Transfer Agent (RTA) of the Company, for the quarter ended June 30, 2026.
Analysis Scores
Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact8/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Emcure Pharmaceuticals Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
Attachments (1)
📄pdf
Download →
EMCURE_07072026181912_IntimationReg74_5_ofDPRegulation.pdf
View document text
Emcure
Ref: EPL/CS/SE/0055/2026 Date: July 07, 2026
National Stock Exchange of India Limited BSE Limited
Exchange Plaza, C-1, Block G, P J Towers,
Bandra Kurla Complex, Bandra (East), Dalal Street,
Mumbai – 400 051 Mumbai- 400 001
Script Symbol: EMCURE Scrip Code/Symbol: 544210/ EMCURE
Dear Sir/Madam,
Subject: Confirmation under Regulation 74(5) of the SEBI (Depositories and Participants)
Regulations, 2018, for the quarter ended June 30, 2026
Please find enclosed herewith a Confirmation Certificate under Regulation 74(5) of
the SEBI (Depositories and Participants) Regulations, 2018, for the quarter ended
June 30, 2026, received from MUFG Intime India Private Limited, the Registrar and Share Transfer
Agent (RTA) of the Company.
You are requested to take the same on your records.
Thanking you,
For Emcure Pharmaceuticals Limited
Amruta Yangalwar
Company Secretary and Compliance Officer
ICSI Membership No: A25687
Encl.: As above
Emcure Pharmaceuticals Limited
Registered Office: Plot No. P-1 & P-2, IT-BT Park, Phase-II, M.I.D.C., Hinjawadi, Pune - 411057, Maharashtra, India
Phone Nos.: +91 20 – 35070033/ 35070000 Fax No.: +91 20 3507 0060
E-mail: corporate@emcure.com Website: www.emcure.com CIN: L24231PN1981PLC024251
MUFG Intime India Private Limited
(Formerly Link Intime India Private Limited)
CIN: U67190MH1999PTC118368
Block No 202, 2nd Floor, Akshay Complex,
Off Dhole Patil Road, Pune - 411001
Tel : +91 20 26161629
Website: https://in.mpms.mufg.com
SEBI Registration no.: INR000004058
Date: April 06, 2026
Emcure Pharmaceuticals Limited
Plot No. P-1 and P-2.
IT-BT Park, Phase II, M.I.D.C.,
Hinjawadi, Pune 411057 Maharashtra, India
Subject: Confirmation Certificate in the matter of Regulation 74(5) of Securities and
Exchange Board of India (Depositories and Participants) Regulations, 2018.
Dear Sir / Madam,
In reference to the above captioned regulation, we hereby confirm that the securities received from the
depository participants for dematerialisation during the quarter ended 31st March 2026, were confirmed
(accepted/rejected) to the depositories by us and that securities comprised in the said certificates have
been listed on the stock exchanges where the earlier issued securities are listed.
We hereby also confirm that the security certificates received for dematerialisation have been
confirmed/rejected and the security certificates received were mutilated and cancelled after due
verification by the depository participant and the name of the depositories have been substituted in the
register of members as the registered owner within the prescribed timelines. We request you to kindly
take note of the above in your records.
Thanking You,
Yours faithfully,
For MUFG Intime India Private Limited
(Formerly known as Link Intime India Private Limited)
Ashok Shetty
Vice President – Corporate Registry
Part of MUFG Pension & Market Services
C-101, Embassy 247, L. B. S. Marg, Vikhroli (West), Mumbai - 400 083. Tel. : +91 22 4918 6000.